Daily as of 3 Nov 16:00 ET
- Price
- between the two $40.33 vs 50 $41.05 / 200 $32.76
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
LBRX | LB PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$40.33
+$1.29 (+3.30%)
LB Pharmaceuticals (LBRX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2026.
The 50 SMA sits above the 200 on the daily, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily and above both on the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 13:30 ET
- Price
- above both $40.92 vs 50 $37.61 / 200 $39.05
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 20 Oct 2026 bar 2 · projected 30 bars out · tested 1 bar
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 20 Oct 2026 | 💀Death | 4-hour | 30 bars out | 1 bar cross test |
About LBRX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$13.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2026
SectorHealthcare
Cap bandsmall